Wilmington, DE – October, 2016 - Phillips & Cohen Associates, Ltd., the deceased account management leader servicing creditors in the US, Canada, UK, Ireland, Australia and New Zealand, announces the appointment of Gelsomina Paolini as Global Chief Financial Officer.

Ms. Paolini has more than twenty years’ experience overseeing worldwide financial planning and strategy initiatives for Fortune 500 and SEC regulated entities. Prior to her joining Phillips & Cohen Associates, she held a variety of global leadership roles with DuPont and Chemours, including Segment Global Financial Officer and Global Strategic Planning Manager.

“I am very excited about joining Phillips & Cohen and to be a part of such a dynamic group”, said Ms. Paolini. “I look forward to working with the Executive team to drive our continued global growth and financial management strategies.” 

Matthew Phillips, Co-Chairman/CEO of Phillips & Cohen commented, “we are thrilled to have Gelsomina join the organization to lead our financial teams in the next phase of our company’s evolution, both domestically and internationally.”

Adam S. Cohen, Co-Chairman/CEO added, “Gelsomina’s extensive experience, knowledge and multilingual capabilities are significant assets to Phillips & Cohen Associates.  We look forward to her input and guidance as we continue to expand in Europe, Asia and the Americas.”

About Phillips & Cohen Associates, Ltd.
Phillips & Cohen Associates, Ltd. is a specialty receivable management company providing customized services to creditors in a variety of unique market segments.  Phillips & Cohen Associates, Ltd is domestically headquartered in Wilmington, DE, with additional offices in Colorado and Florida as well as international offices in the UK, Canada, and Australia.  For more information about Phillips & Cohen Associates visit
www.phillips-cohen.com. PCA provides Equal Employment Opportunity for all individuals regardless of race, color, religion, gender, age, national origin, disability, marital status, sexual orientation, veteran status, genetic information and any other basis protected by federal, state or local laws.